A detailed history of Azzad Asset Management Inc /Adv transactions in Novo Nordisk A S stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 41,107 shares of NVO stock, worth $3.49 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
41,107
Previous 26,376 55.85%
Holding current value
$3.49 Million
Previous $3.76 Billion 30.01%
% of portfolio
0.55%
Previous 0.44%

Shares

55 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$119.07 - $145.42 $1.75 Million - $2.14 Million
14,731 Added 55.85%
41,107 $4.89 Billion
Q2 2024

Jul 30, 2024

SELL
$122.71 - $146.91 $1.08 Million - $1.29 Million
-8,792 Reduced 25.0%
26,376 $3.76 Billion
Q1 2024

Apr 19, 2024

BUY
$102.11 - $135.92 $19,707 - $26,232
193 Added 0.55%
35,168 $4.52 Billion
Q4 2023

Apr 01, 2024

BUY
$87.78 - $105.45 $102,088 - $122,638
1,163 Added 3.44%
34,975 $3.62 Billion
Q3 2023

Apr 01, 2024

BUY
$90.94 - $199.54 $1.53 Million - $3.35 Million
16,784 Added 98.57%
33,812 $3.07 Billion
Q2 2023

Apr 01, 2024

BUY
$155.98 - $172.65 $11,542 - $12,776
74 Added 0.44%
17,028 $2.76 Billion
Q1 2023

Apr 01, 2024

SELL
$132.34 - $159.14 $257,665 - $309,845
-1,947 Reduced 10.3%
16,954 $2.7 Billion
Q4 2022

Apr 01, 2024

SELL
$102.55 - $135.33 $2.21 Million - $2.92 Million
-21,593 Reduced 53.32%
18,901 $2.56 Billion
Q3 2022

Apr 01, 2024

SELL
$95.28 - $116.93 $299,179 - $367,160
-3,140 Reduced 7.2%
40,494 $3.29 Billion
Q2 2022

Apr 01, 2024

BUY
$103.24 - $121.81 $2.33 Million - $2.75 Million
22,564 Added 107.09%
43,634 $3.86 Billion
Q1 2022

Apr 01, 2024

BUY
$93.1 - $112.54 $22,064 - $26,671
237 Added 1.14%
21,070 $2.34 Billion
Q4 2021

Apr 01, 2024

SELL
$95.88 - $117.08 $169,324 - $206,763
-1,766 Reduced 7.81%
20,833 $2.33 Billion
Q3 2021

Apr 01, 2024

SELL
$84.42 - $106.62 $444,555 - $561,460
-5,266 Reduced 18.9%
22,599 $2.17 Billion
Q2 2021

Apr 01, 2024

BUY
$67.66 - $84.76 $205,686 - $257,670
3,040 Added 12.25%
27,865 $2.33 Billion
Q1 2021

Apr 01, 2024

BUY
$67.06 - $75.82 $92,274 - $104,328
1,376 Added 5.87%
24,825 $1.67 Billion
Q4 2020

Apr 01, 2024

BUY
$63.89 - $73.8 $44,020 - $50,848
689 Added 3.03%
23,449 $1.64 Billion
Q3 2020

Apr 01, 2024

BUY
$63.69 - $70.22 $61,842 - $68,183
971 Added 4.46%
22,760 $1.58 Billion
Q2 2020

Apr 01, 2024

SELL
$58.54 - $67.94 $224,559 - $260,617
-3,836 Reduced 14.97%
21,789 $1.43 Billion
Q1 2020

Apr 01, 2024

SELL
$49.46 - $64.78 $1.05 Million - $1.38 Million
-21,289 Reduced 45.38%
25,625 $1.54 Billion
Q4 2019

Apr 01, 2024

SELL
$49.86 - $58.26 $7,877 - $9,205
-158 Reduced 0.34%
46,914 $2.88 Billion
Q3 2019

Apr 01, 2024

BUY
$47.54 - $53.43 $996,676 - $1.12 Million
20,965 Added 80.3%
47,072 $2.73 Billion
Q2 2019

Apr 01, 2024

BUY
$46.79 - $52.47 $110,798 - $124,248
2,368 Added 9.98%
26,107 $1.33 Billion
Q1 2019

Apr 01, 2024

SELL
$46.36 - $52.63 $534,901 - $607,244
-11,538 Reduced 32.71%
23,739 $1.24 Billion
Q4 2018

Apr 01, 2024

SELL
$41.54 - $47.25 $128,732 - $146,427
-3,099 Reduced 8.08%
35,277 $1.63 Billion
Q3 2018

Apr 01, 2024

SELL
$46.76 - $51.24 $173,666 - $190,305
-3,714 Reduced 8.82%
38,376 $1.81 Billion
Q2 2018

Apr 01, 2024

BUY
$44.29 - $50.42 $1.86 Million - $2.12 Million
42,090 New
42,090 $1.94 Billion
Q1 2018

Apr 03, 2024

BUY
$48.49 - $58.14 $50,575 - $60,640
1,043 Added 2.41%
44,244 $2.18 Billion
Q4 2017

Apr 03, 2024

BUY
$47.53 - $53.73 $46,199 - $52,225
972 Added 2.3%
43,201 $2.32 Billion
Q3 2017

Apr 03, 2024

SELL
$41.15 - $49.22 $141,967 - $169,809
-3,450 Reduced 7.55%
42,229 $2.03 Billion
Q2 2017

Apr 03, 2024

BUY
N/A
2,869 Added 6.7%
45,679 $1.96 Billion
Q1 2017

Apr 03, 2024

BUY
N/A
20,706 Added 93.68%
42,810 $1.47 Billion
Q4 2016

Apr 03, 2024

SELL
N/A
-293 Reduced 1.31%
22,104 $793 Million
Q3 2016

Apr 03, 2024

BUY
N/A
684 Added 3.15%
22,397 $932 Million
Q2 2016

Apr 03, 2024

BUY
N/A
3,741 Added 20.82%
21,713 $1.17 Billion
Q1 2016

Apr 03, 2024

BUY
N/A
3,442 Added 23.69%
17,972 $974 Million
Q4 2015

Apr 03, 2024

BUY
N/A
251 Added 1.76%
14,530 $844 Million
Q3 2015

Apr 03, 2024

BUY
N/A
1,101 Added 8.35%
14,279 $775 Million
Q2 2015

Apr 03, 2024

BUY
N/A
4,741 Added 56.19%
13,178 $722 Million
Q1 2015

Apr 03, 2024

BUY
N/A
473 Added 5.94%
8,437 $450 Million
Q4 2014

Apr 03, 2024

SELL
N/A
-459 Reduced 5.45%
7,964 $337 Million
Q3 2014

Apr 03, 2024

BUY
N/A
241 Added 2.95%
8,423 $401 Million
Q2 2014

Apr 03, 2024

BUY
N/A
104 Added 1.29%
8,182 $378 Million
Q1 2014

Apr 03, 2024

BUY
N/A
6,297 Added 353.57%
8,078 $369 Million
Q4 2013

Apr 03, 2024

SELL
N/A
-54 Reduced 2.94%
1,781 $329 Million
Q2 2013

Apr 03, 2024

BUY
N/A
4 Added 0.22%
1,835 $310 Million
Q1 2013

Apr 03, 2024

SELL
N/A
-33,144 Reduced 94.76%
1,831 $296 Million
Q4 2012

Apr 08, 2024

SELL
N/A
-5,362 Reduced 71.87%
2,099 $343 Million
Q3 2012

Apr 08, 2024

BUY
N/A
1,421 Added 23.53%
7,461 $1.18 Billion
Q2 2012

Apr 08, 2024

BUY
N/A
443 Added 7.91%
6,040 $878 Million
Q1 2012

Apr 08, 2024

SELL
N/A
-27 Reduced 0.48%
5,597 $776 Million
Q4 2011

Apr 08, 2024

SELL
N/A
-125 Reduced 2.17%
5,624 $648 Million
Q3 2011

Apr 08, 2024

BUY
N/A
48 Added 0.84%
5,749 $572 Million
Q2 2011

Apr 08, 2024

SELL
N/A
-203 Reduced 3.44%
5,701 $714 Million
Q1 2011

Apr 08, 2024

SELL
N/A
-185 Reduced 3.04%
5,904 $739 Million
Q4 2010

Apr 08, 2024

SELL
N/A
-28,886
6,089 $685 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.